Omnibus IV military medical research and development

Active Awarded Last action

Contract number
HT001122D0053
Awardee
Awarding agency
Task orders
5 $18,336,583 obligated

Award facts

Opportunity
Combined order value
  • $19,771,708 Current, with exercised options
  • $43,409,373 Potential, with all options
Last date to order 44% complete
IDV ceiling <1% used
$10,000,000,000.00
Award type
Multiple award
Who can order
Defense agencies
Set-aside
No set-aside
Competition
Full and Open Competition · 126 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded an indefinite-delivery contract to Culmen International, LLC on June 20, 2022, with a $10 billion ceiling for military medical research and development services. This is a multiple-award IDIQ.

Place of performance spans Georgia, Silver Spring Maryland, Portsmouth Virginia, and Falls Church Virginia, with subordinate performance across Defense Health Agency and subordinate medical research commands.

The originating solicitation was posted November 13, 2020 and sought scientific, technical, and administrative support for medical readiness systems biology research, clinical research support, and implementation science services to advance evidence-based medical research implementation across the Department of Defense.

The IDIQ runs through June 19, 2032. Culmen qualifies as a small business by SBA standards and holds Total Small Business set-aside designations on select delivery orders under this vehicle.

Recent task order activity includes a $15.355 million order issued March 13, 2025 (cost-plus-fixed-fee through March 12, 2030) for scientific, technical, and administrative support for infectious disease research and surveillance to identify and characterize medical threats to the warfighter in area of responsibility, performed in Georgia. The Defense Health Agency issued a $14.179 million cost-plus-fixed-fee order on June 24, 2024 (Total Small Business set-aside, through July 21, 2029) for implementation science support services in Silver Spring, Maryland. A $12.458 million order (Total Small Business set-aside, cost-plus-fixed-fee, through August 19, 2029) was issued November 20, 2024 for medical readiness systems biology research support and drug development for diarrheal and bacterial diseases in Silver Spring, Maryland. A $1.413 million firm-fixed-price order for clinical research support services was issued September 28, 2024 (Total Small Business set-aside, through September 27, 2026) in Portsmouth, Virginia. Vysnova Partners, LLC, a Culmen subsidiary, received a $2,500 firm-fixed-price order on June 19, 2023 for military medical research and development services in Falls Church, Virginia (completed June 19, 2023).

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 $0
Other Administrative Action P00003 · Omnibus IV military medical research and development services $0
Novation Agreement P00002 · Omnibus IV indefinite delivery indefinite quantity contract for military medical research and development services $0
Other Administrative Action P00001 · Omnibus IV military medical research and develoopment $0
Original award $0

Quick answers

Who was awarded contract HT001122D0053?

HT001122D0053 was awarded to Culmen International, LLC by Defense Health Agency (Department of Defense) on June 20, 2022.

How much is contract HT001122D0053 worth?

Orders under HT001122D0053 have obligated $18,336,583. Their combined current value, with exercised options, is $19,771,708. Their combined potential value, with all options, is $43,409,373. HT001122D0053's own ceiling is $10,000,000,000.

How many orders have been placed under contract HT001122D0053?

5 orders have been placed under HT001122D0053, the latest on March 11, 2025.

Who can order from contract HT001122D0053?

HT001122D0053 is a multiple award indefinite delivery contract. Defense agencies can place orders on it.

Is contract HT001122D0053 part of a contract vehicle?

Yes. HT001122D0053 is part of Omnibus IV Military Medical Research And Development (OMNIBUS IV).

Was contract HT001122D0053 competed?

The extent of competition for HT001122D0053 was full and open competition. The government received 126 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV